I Hate Dialysis Message Board
Dialysis Discussion => Dialysis: News Articles => Topic started by: okarol on January 19, 2011, 10:27:12 PM
-
DaVita Inc. (NYSE: DVA) Posts Large Volume Increase, Hits $71.06
January 18th, 2011 • View Comments • Filed Under • by ABMN Staff
Shares of DaVita Inc. (NYSE: DVA) saw unusually high trading volume on Tuesday. Approximately 567,579 shares changed hands during mid-day trading, an increase of -15.93% from the previous session. The stock last traded at $71.06.
On a related note, analysts at Avondale Partners initiated coverage on shares of DaVita Inc. in a research note to investors on Tuesday, December 14th. They set a “market perform” rating and a $70.00 price target on the stock. Separately, analysts at Goldman Sachs (NYSE: GS) initiated coverage on shares of DaVita Inc. in a research note to investors on Thursday, December 9th. They set a “buy” rating and a $90.00 price target on the stock.
DaVita Inc. (DaVita) is a provider of dialysis services in the United States for patients suffering from chronic kidney failure, also known as end stage renal disease (ESRD). As of December 31, 2009, the Company operated or provided administrative services to 1,530 outpatient dialysis centers located in 43 states and the District of Columbia, serving approximately 118,000 patients. DaVita also provides acute inpatient dialysis services in approximately 720 hospitals and related laboratory services. Its dialysis and related lab services business accounts for approximately 95% of its consolidated net operating revenues. Other ancillary services and strategic initiatives accounts for approximately 5% of its consolidated net operating revenues and relate primarily to its core business of providing renal care services. The Company provides Dialysis and Related Lab Services, and Ancillary services and strategic initiatives.
DaVita Inc. (NYSE: DVA) traded down 0.53% during mid-day trading on Tuesday. The stock has a 52 week low of $56.58 and a 52 week high of $74.61. Its 50-day moving average is $70.72 and its 200-day moving average is $67.37. The company has a market cap of $6.885 billion and a price-to-earnings ratio of 16.64.
Stay on top of analysts' coverage with American Banking & Market News' daily email newsletter that provides a concise list of analysts’ upgrades, analysts’ downgrades and analysts’ price target changes for each day. Click Here to register.
http://www.americanbankingnews.com/2011/01/18/davita-inc-nyse-dva-posts-large-volume-increase-hits-71-06/